Call to arms as UK falls back in medicines manufacturing
Pharma Phorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition.
Tue.Jan 24, 2023
105 
AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships
PharmaVoice
JANUARY 24, 2023
A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra
Join 24,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Nine for 2023, part three: thriving or surviving?
Pharma Phorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
Physician Opinions on Burnout in 2022 – Blog
InCrowd
JANUARY 24, 2023
In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Can genetic data be a magic bullet for drug R&D?
Pharma Phorum
JANUARY 24, 2023
Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.
Can machine learning accelerate drug formulation?
Outsourcing Pharma
JANUARY 24, 2023
Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations. Clinical Development
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds
Fierce Healthcare
JANUARY 24, 2023
Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds dmuoio Tue, 01/24/2023 - 10:23
Largest global clinical site hires all-female key leaders in Europe
European Pharmaceutical Review
JANUARY 24, 2023
Velocity Clinical Research , the largest integrated research site organisation globally, has made three all-female key leadership hires. This move strengthens its European senior executive team as the firm continues its expansion in the region.
With the X-waiver repealed, officials urge providers to begin prescribing buprenorphine for opioid addiction
Fierce Healthcare
JANUARY 24, 2023
With the X-waiver repealed, officials urge providers to begin prescribing buprenorphine for opioid addiction dmuoio Tue, 01/24/2023 - 14:52
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo
Fierce Pharma
JANUARY 24, 2023
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo fkansteiner Tue, 01/24/2023 - 16:13
Blues to press Congress to expand site-neutral payment reforms to more outpatient clinics
Fierce Healthcare
JANUARY 24, 2023
Blues to press Congress to expand site-neutral payment reforms to more outpatient clinics rking Tue, 01/24/2023 - 11:30
Amazon unveils $5 subscription service for generics
Pharma Phorum
JANUARY 24, 2023
Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients’ homes in return for a $5 monthly fee.
Industry Voices—Key to rural hospital survival: Sustainable solutions for patient financial engagement
Fierce Healthcare
JANUARY 24, 2023
Industry Voices—Key to rural hospital survival: Sustainable solutions for patient financial engagement hlandi Tue, 01/24/2023 - 09:47
US FDA clears Transcenta’s IND for Rett syndrome treatment
Pharmaceutical Technology
JANUARY 24, 2023
The US Food and Drug Administration (FDA) has granted clearance for Neurogene’s investigational new drug (IND) application for NGN-401 to treat Rett syndrome.
Providers jostle to lead way if FDA makes COVID vaccination a yearly jab
Fierce Healthcare
JANUARY 24, 2023
Providers jostle to lead way if FDA makes COVID vaccination a yearly jab fdiamond Tue, 01/24/2023 - 08:46
Bayer’s oncology business looks to collect $10B in sales by 2030, exec says
Fierce Pharma
JANUARY 24, 2023
Bayer’s oncology business looks to collect $10B in sales by 2030, exec says zbecker Tue, 01/24/2023 - 09:14
Managed care plans, states can now text Medicaid beneficiaries to warn of enrollment changes
Fierce Healthcare
JANUARY 24, 2023
Managed care plans, states can now text Medicaid beneficiaries to warn of enrollment changes rking Tue, 01/24/2023 - 13:59
Georgia Tech spinout bags cash for nucleic acid delivery R&D
Fierce Pharma
JANUARY 24, 2023
Georgia Tech spinout bags cash for nucleic acid delivery R&D ntaylor Tue, 01/24/2023 - 10:10
Leveraging Real-World Patient Journeys at Scale for Clinical Trial Strategies
PharmExec
JANUARY 24, 2023
Readily available real-world data and advanced solutions are being used to stitch together the full patient journey, and these longitudinal insights are being used to identify and characterize trial populations and inform clinical trial design and execution strategies.
Advancing node-to-brain delivery, team treats stoke in rodents using intranasal antibody
Fierce Pharma
JANUARY 24, 2023
Advancing node-to-brain delivery, team treats stoke in rodents using intranasal antibody ntaylor Tue, 01/24/2023 - 05:45
Colorcon Acquires Airnov Healthcare Packaging
Pharmaceutical Commerce
JANUARY 24, 2023
Transaction expected to close early this year us
Modernizing Therapeutic Cell Production
Pharma Mirror
JANUARY 24, 2023
Science-based innovation for manufacturing high quality cells challenges dogma and terminology Cell and gene therapies are dominating the world of drug development.
Physician Opinions on Burnout in 2022 – Report
InCrowd
JANUARY 24, 2023
In November of 2022, InCrowd surveyed 500 US physicians to track burnout. Download the full report to learn more about this research. The post Physician Opinions on Burnout in 2022 – Report appeared first on InCrowd. Report
Novo Nordisk accused of violating FDA’s Fair Balance advertising policy
Pharmafile
JANUARY 24, 2023
Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo Nordisk’s weight loss drug Wegovy appeared on CBS’s 60 Minutes news segment about obesity. read more Sales and Marketing
AmerisourceBergen to Update Name to Cencora
Pharmaceutical Commerce
JANUARY 24, 2023
Reflects company’s identity and pharma supply chain impact us
Diabetes drug, originally developed for cats, approved for human use
Pharmafile
JANUARY 24, 2023
TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of adult patients with type 2 diabetes. The drug was originally indicated for cats with diabetes.
Report reveals murky picture of clinical trial diversity gains
PharmaVoice
JANUARY 24, 2023
Data discrepancies between study phases and indications could provide clues about why some trials have better racial and ethnic diversity than others
WHO issues a “call to action” after cough syrup deaths
Pharmafile
JANUARY 24, 2023
WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, detect and respond to incidences of illegitimate medical products.
Charles Collier Joins Fuld & Company as Senior Vice President, Consulting Research & Analytics
Fuld
JANUARY 24, 2023
BOSTON – Jan 24, 2023 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Charles Collier to the role of Senior Vice President, Consulting Research & Analytics.
Europe plans further antibiotic shortage countermeasures
Pharmafile
JANUARY 24, 2023
With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to look into contingency plans to deal with the concerning shortages of certain antibiotics.
Sandoz bulks up with Mycamine ahead of spin-off
Pharma Phorum
JANUARY 24, 2023
With a separation from parent company Novartis now confirmed, Sandoz has moved to strengthen its revenue base with the acquisition of global rights to mainstay antifungal drug Mycamine from Japan’s Astellas.
Sanofi, CytoReason expand AI deal into IBD
Pharma Phorum
JANUARY 24, 2023
Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the field of inflammatory bowel disease (IBD).
finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation
Pharmafile
JANUARY 24, 2023
Published date: 24/01/2023 Summary: London, 24th January - finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the sale of Therapy Equipment Limited to ESAB Corporation. Founded in 1983, Therapy Equipment Ltd.
Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work
Fierce Pharma
JANUARY 24, 2023
Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work ntaylor Tue, 01/24/2023 - 05:42
Let's personalize your content